Acute Biologic Crisis Lecture

7,767 views

Published on

Published in: Health & Medicine, Business
2 Comments
19 Likes
Statistics
Notes
No Downloads
Views
Total views
7,767
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
0
Comments
2
Likes
19
Embeds 0
No embeds

No notes for slide

Acute Biologic Crisis Lecture

  1. 1. JOFRED M. MARTINEZ, RN
  2. 2. FALL IN PAO2 TO LESS THAN 50 MMHGRISE IN PACO2 TO GRETAER THAN 50 MMHGMECHANISMS LEADING TO ARF
  3. 3. ALVEOLAR HYPOVENTILATIONDIFFUSION ABNORMALITIESVENTILATION–PERFUSION MISMATCHINGMECHANISMS LEADING TO ARF
  4. 4. DECREASED RESPIRATORY DRIVESEVERE BRAIN INJURY, MULTIPLE SCLEROSIS, SEDATIVES,HYPOTHYROIDISMDYSFUNCTION OF THE CHEST WALLMYASTHENIA GRAVIES, POLIOMYELITIS, MUSCULARDYSTROPHYDYSFUNCTION OF LUNG PARENCHYMAPLEURAL EFFUSION, UPPER AIRWAY OBSTRUCTIONOTHER CAUSESANESTHETIC AGENTS, MEDICATIONSETIOLOGY
  5. 5. RESTLESSNESS, FATIGUE, HEADACHE,DYSPNEA, TACHYCARDIA, AND INCREASEDBLOOD PRESSUREHYPOXEMIA, CONFUSION, LETHARGY,TACHYCARDIA, TACHYPNEA, CENTRALCYANOSIS, USE OF ACCESSORY MUSCLES,DECREASED BREATH SOUNDSMANIFESTATIONS
  6. 6. ENDOTRACHEAL INTUBATIONMECHANICAL VENTILATIONOXYGEN THERAPYMANAGEMENT
  7. 7. ASSIST IN INTUBATIONMAINTAIN MECHANICAL VENTILATIONASSESSMENT OF VITAL SIGNS AND ABG’SPREVENT COMPLICATIONSFACILITATE LEARNINGNURSING MANAGEMENT
  8. 8. SUDDEN AND PROGRESSIVE PULMONARY EDEMAINCREASING BILATERAL INFILTRATES ON CHEST X-RAYHYPOXEMIA REFRACTORY TO OXYGENSUPPLEMENTATIONREDUCED LUNG COMPLIANCECHARACTERISTICS
  9. 9. ASPIRATIONGASTRIC SECRETION, DROWNING, HYDROCARBONSDRUG INGESTION AND OVERDOSEHEMATOLOGIC DISORDERSDIC, MASSIVE TRANSFUSIONSPROLONGED INHALATION OF HIGH CONCENTRATIONSOF OXYGEN, SMOKE, OR CORROSIVE SUBSTANCESLOCALIZED INFECTIONETIOLOGY
  10. 10. METABOLIC DISORDERSPANCREATITIS, UREMIASHOCKTRAUMAPULMONARY CONTUSION, MULTIPLE FRACTURES, HEAD INJURYFAT OR AIR EMBOLISMSYSTEMIC SEPSISETIOLOGY
  11. 11. INTERCOSTAL RETRACTIONS AND CRACKLESBILATERAL INFILTRATES IN X-RAYRATIO OF PARTIAL PRESSURE OF OXYGEN OFARTERIAL BLOOD TO FRACTION OF INSPIREDOXYGEN (PAO2/FIO2) LESS THAN 200 MMHGMANIFESTATIONS
  12. 12. IDENTIFICATION AND TREATMENT OFUNDERLYING CONDITIONOXYGEN THERAPYINTUBATION AND MECHANICAL VENTILATIONCIRCULATORY SUPPORT, ADEQUATE FLUIDVOLUME, AND NUTRITIONAL SUPPORTMANAGEMENT
  13. 13. POSITIVE END EXPIRATORY PRESSURE (PEEP)MANAGE SYSTEMIC HYPOTENSIONPULMONARY ARTERY PRESSURE MONITORINGMANAGEMENT
  14. 14. HUMAN RECOMBINANT INTERLEUKIN-1RECEPTOR ANTAGONISTNEUTROPHIL INHIBITORSPULMONARY-SPECIFIC VASODILATORSSURFACTANT REPLACEMENT THERAPYANTIBIOTICSANTIOXIDANT THERAPYCORTICOSTEROIDSMANAGEMENT
  15. 15. CHEST PHYSIOTHERAPYMAINTENANCE OF OXYGEN THERAPYSUCTIONING OF SECRETIONSTURNING CLIENT TO SIDES FREQUENTLYMANAGE ANXIETYFACILITATE LEARNINGNURSING MANAGEMENT
  16. 16. PNEUMOTORAXHEMOTHORAXPYOTHORAXHYDROTHORAXTYPES
  17. 17. TRAUMATHORACIC SURGERYPOSITIVE PRESSURE VENTILATIONTHORACENTESISCVP LINE INSERTIONEMPHYSEMACANCERINFECTIONETIOLOGY
  18. 18. SUDDEN, SHARP CHEST PAINSHORTNESS OF BREATHANXIETY / RESTLESSNESSTACHYCARDIA & TACHYPNEACHEST ASSYMETRYHYPERROSONANCE ON CHEST PERCUSSIONMANIFESTATIONS
  19. 19. HIGH FOWLER’S POSITIONPAIN MANAGEMENTOXYGEN THERAPYCHEST TUBES / THORACENTESISMONITOR ARTERIAL BLOOD GASESMONITOR FOR SHOCKMANAGEMENT
  20. 20. TRANSMURAL INFARCTSUBENDOCARDIAL INFARCTINTRAMURAL INFARCTIONMI CLASSIFICATIONS
  21. 21. PAINCRUSHING, SEVERE, PROLONGEDUNRELIEVED BY REST OR NITROGLYCERINERADIATES TO ONE OR BOTH ARMS,NECK AND BACKLEVINE’S SIGNCLINICAL MANIFESTATIONS
  22. 22. ANXIETY AND APPREHENSIONSHOCKFEVERACUTE PUMONARY EDEMACLINICAL MANIFESTATIONS
  23. 23. ELEVATED CK-MBELEVATED LDHELEVATED TROPONINELEVATED ASTLABORATORY FINDINGS
  24. 24. DYSRHYTHMIASCARDIOGENIC SHOCKTHROMBOEMBOLISMPERICARDITISRUPTURE OF THE MYOCARDIUMVENTRICULAR ANEURYSMCONGESTIVE HEART FAILURECOMPLICATIONS OF MI
  25. 25. P WAVEPR INTERVALQRS COMPLEXST SEGMENTT WAVEWAVES AND COMPLEXES
  26. 26. HYPOKALEMIAU-WAVEDEPRESSED ST SEGMENTSHORT T WAVEABNORMAL WAVES AND COMPLEXES
  27. 27. HYPERKALEMIAPROLONGED QRS COMPLEXELEVATED ST SEGMENTPEAKED T WAVEABNORMAL WAVES AND COMPLEXES
  28. 28. ELEVATED ST SEGMENTINVERTED T WAVEPATHOLOGIC Q WAVEMYOCARDIAL INFARCTION
  29. 29. 0 LEVEL OF H20 MANOMETER AT THE LEVEL OFRIGHT, MID-AXILLARY, 4TH INTERCOSTAL SPACENORMAL READINGSUPERIOR VENA CAVA: 0-12 CM H20RIGHT ATRIUM: 5-12 CM H20CENTRAL VENOUS PRESSURE
  30. 30. RIGHT AND LEFT VENTRICULAR FUNCTIONPULMONARY ARTERY PRESSURESCARDIAC OUTPUTARTERIAL-VENOUS OXYGEN DIFFERENCECENTRAL VENOUS PRESSURE
  31. 31. ELEVATED PAP AND CPAP INDICATES LEFT SIDEDCONGESTIVE HEART FAILURESWAN-GANZ CATHETERNORMAL READINGPAP: 4-12 MMHGCPAP: 4-12 MMHGPRACTICE ASEPSISPAP AND PCWP
  32. 32. ANALGESICTHROMBOLYTICSANTICOAGULANTSBETA-ADRENERGIC BLOCKING AGENTSDIAZEPAM (VALIUM)MANAGEMENT
  33. 33. SUPPLEMENTAL OXYGEN VIA NASAL CANNULACARDIAC MONITORINGPERCUTANEOUS TRANSLUMINALCORONARY ANGIOPLASTY (PTCA)LOW CHOLESTEROL & LOW SALT DIETBED RESTMANAGEMENT
  34. 34. PROMOTE OXYGEN AND TISSUE PERFUSIONPROMOTE COMFORTPROMOTE ACTIVITYPROMOTE NUTRITION AND ELIMINATIONPROMOTE RELIEF OF ANXIETYFACILITATE LEARNINGNURSING MANAGEMENT
  35. 35. DIRECT DAMAGE TO THE HEARTVENTRICULAR OVERLOADCONSTRICTION OF VENTRICLESETIOLOGY
  36. 36. DYSPNEAPULMONARY EDEMAPULSUS ALTERNANSPOLYCYTHEMIAELEVATED PAP & PCWPFATIGUE & WEAKNESSLEFT SIDED CHF
  37. 37. LEFT SIDED CHF
  38. 38. NECK VEIN ENGORGEMENTPOTAL HYPERTENSIONPERIPHERAL EDEMAHEMORRHOIDS & VARICOSITIESELEVATED CVPRIGHT SIDED CHF
  39. 39. RIGHT SIDED CHF
  40. 40. DIGITALIS THERAPYDIURETIC THERAPYVASODILATORSSYMPATHOMIMETICSMANAGEMENT
  41. 41. LOW SODIUM DIETBALANCED PROGRAM OF ACTIVITY AND RESTOXYGEN THERAPYMANAGEMENT
  42. 42. PROVIDE OXYGENATIONPROMOTE REST AND ACTIVITYDECREASE ANXIETYMAINTAIN FLUID BALANCEPROMOTE PROPER NUTRITIONPROMOTE ELIMINATIONFACILITATE LEARNINGNURSING MANAGEMENT
  43. 43. HIGH FOWLER’S POSITIONMORPHINE SULFATE 10 TO 15 MGOXYGEN THERAPY 40% TO 70%AMINOPHYLLINE IVRAPID DIGITALIS ADMINISTRATIONDIURETIC THERAPYVASODILATORSDOPAMINEEMERGENCY MANAGEMENT
  44. 44. OLIGURIC PHASEDECREASED URINE OUTPUT, INCREASED BUN,SERUM CREATININE, HYPERTENSION, EDEMAAND METABOLIC ACIDOSIS1 TO 3 WEEKSTHREE STAGES OF ARF
  45. 45. DIURETIC PHASEINCREASED URINE OUTPUT TO 3-5 L/DAYEXCESSIVE LOSS OF POTASSIUM1 WEEKTHREE STAGES OF ARF
  46. 46. RECOVERY PHASE3 TO 12 MONTHSAVOID NEPHROTOXIC DRUGSTHREE STAGES OF ARF
  47. 47. FLUID CONTROLELECTROLYTE CONTROLHIGH CALORIE, HIGH CARBOHYDRATE, LOWPROTEIN, LOW POTASSIUM AND LOW SODIUMMANAGEMENT
  48. 48. RIGHT HEMIPLEGIARIGHT VISUAL FIELD DEFECTAPHASIAALTERED INTELLECTUAL ABILITYSLOW, CAUTIOUS BEHAVIORLEFT CEREBROVASCULAR ACCIDENT
  49. 49. PARALYSIS
  50. 50. LEFT HEMIPLEGIARIGHTLEFT VISUAL FIELD DEFECTSPATIAL-PERCEPTUAL FIELD DEFECTINCREASED DISTRACTABILITYIMPULSIVE BEHAVIORRIGHT CEREBROVASCULAR ACCIDENT
  51. 51. CEREBROVASCULAR ACCIDENT
  52. 52. PROMOTE COMMUNICATIONPROMOTE NUTRITIONPROMOTE ACTIVITYPROMOTE ELIMINATIONPROVIDE EMOTIONAL SUPPORTMANAGEMENT
  53. 53. RESTLESSNESS INITIAL SIGNALTERED LEVEL OF CONSCIOUSNESSAFFECTION OF ASCENDING RETICULARACTIVATING SYSTEMHEADACHENAUSEA AND VOMITINGMANIFESTATIONS
  54. 54. CUSHING’S TRIADDIPLOPIACRANIAL NERVE VIPUPILLARY CHANGESANISOCURIAPINPOINT PUPILS – PONS INVOLVEMENTFIXED DILATED PUPILS – BRAIN HERNIATIONMANIFESTATIONS
  55. 55. PAPILLEDEMACOMPRESSION OF CRANIAL NERVE IILATERALIZING SIGNDECUSSATION OF MOTOR FIBERS AT MEDULLAOBLONGATABRAIN STEM IMPAIREMENTDOLL’S EYE SIGNDECORTICATIONMANIFESTATIONS
  56. 56. BRAINSTEM FUNCTION IMPAIREMENTALTERATIONS IN SENSORY FUNCTION, MOTORFUNCTION, LANGUAGE & SPEECH, BOWEL &BLADDER FUNCTIONMANIFESTATIONS
  57. 57. INCREASED ICP
  58. 58. HOB ELVATION TO 15 TO 30 DEGREESADEQUATE OXYGENATIONSAFETYRESTMANAGEMENT
  59. 59. NAUSEA AND VOMITINGVALSALVA MANEUVEROVER SUCTIONING OF SECRETIONSRESTRAINTSRECTAL EXAMINATIONENEMABENDING OR STOOPINGFACTORS THAT INCREASE ICP
  60. 60. MONITOR NEURO VITAL SIGNSCONTROL HYPERTENSIONRESTRICT FLUID INTAKECRANIOTOMYMANAGEMENT
  61. 61. DIURETICSDEXAMETHASONEANTICONVULSANTSANTICOAGULANTSMANAGEMENT
  62. 62. GRAND MAL SEIZUREPETIT MAL SEIZUREJACKSONIAN (FOCAL) SEIZUREPSYCHOMOTOR SEIZUREFEBRILE SEIZURESTATUS EPILEPTICUSTYPES OF SEIZURE
  63. 63. PROVIDE SAFETYMAINTAIN PATENT AIRWAYOBSERVE AND DOCUMENTMANAGEMENT
  64. 64. ANTICONVULSANTSPHENYTOIN (DILANTIN), MEPHENYTOIN (MESANTOIN),ETHOTOINBARBITURATESAMOBARBITAL (AMYTAL), MEPHOBARBITAL(MEBARAL), PHENOBARBITAL (LUMINAL),PRIMIDONE (MYSOLINE)MANAGEMENT
  65. 65. SUCCINIMIDESETHOSUXIMIDE (ZARONTIN), METHSUXIMIDE(CELONTIN), PHENSUXIMIDE (MILONTIN)OXAZOLIDONES / OXAZOLIDINEDIONEPARAMETHADIONE (PARADIONE),TRIMETHADIONE (TRIDIONE)MANAGEMENT
  66. 66. BENZODIAZEPINESCLONAZEPAM (KLONOPIN), CLORAZEPATEDIPOTASSIUM (TRANXENE), DIAZEPAM (VALIUM),LORAZEPAM (ATIVAN)IMINOSTILBENESCARBAMAZEPINE (TEGRETOL),OXCARBAZEPINE (TRILEPTAL)MANAGEMENT
  67. 67. VALPROATEVALPROIC ACID (DEPAKENE),DIVALPROEX NA (DEPAKOTE)MANAGEMENT
  68. 68. CONCUSSIONCONTUSIONLACERATIONBRAIN COMPRESSIONTYPES OF HEAD TRAUMA
  69. 69. SIGNS & SYMPTOMS OF INCREASED ICPCSF LEAK FROM EARS AND NOSEBATTLE’S SIGNMANIFESTATIONS
  70. 70. HEAD INJURY
  71. 71. CARE FOR CLIENT WITH INCREASED ICFMONITOR DRAINAGE FROM NOSE AND EARSMONITOR FOR SIGNS & SYMPTOMS OFMENINGITIS, ATELECTASIS, PNEUMONIA, UTIMANAGEMENT
  72. 72. CARE FOR CLIENT WITH INCREASED ICFMONITOR DRAINAGE FROM NOSE AND EARSMONITOR FOR SIGNS & SYMPTOMS OFMENINGITIS, ATELECTASIS, PNEUMONIA, UTI
  73. 73. INSULIN OR ORAL HYPOGLYCEMICS OVERDOSEOMISSION OF MEALS OR TOO LITTLE FOODEXCESSIVE ACTIVITYGASTROINTESTINAL UPSETHYPOGLYCEMIA
  74. 74. HUNGERNERVOUSNESSPALPITATIONSSWEATINGTACHYCARDIATREMORSMILD HYPOGLYCEMIA MANIFESTATIONS
  75. 75. CONFUSIONDOUBLE VISIONDROWSINESSEMOTIONAL CHANGESHEADACHEIMPAIRED COORDINATIONINABILITY TO CONCENTRATEMODERATE HYPOGLYCEMIA MANIFESTATIONS
  76. 76. IRRATIONAL OR COMBATIVE BEHAVIORLIGHT-HEADEDNESSMEMORY LAPSESNUMBNESS OF LIPS AND TONGUESLURRED SPEECHMODERATE HYPOGLYCEMIA MANIFESTATIONS
  77. 77. INABILITY TO SWALLOWLOSS OF CONSCIOUSNESSSEIZURESSEVERE HYPOGLYCEMIA MANIFESTATIONS
  78. 78. 10 TO 15 G OF FAST ACTING SIMPLECARBOHYDRATESCOMMERCIALLY PREPARED GLUCOSE TABLETS6 TO 10 SWEET HARD CANDY4 TSP OF SUGAR1/2 CUP OF FRUIT JUICE OR REGULAR SOFTDRINK3 GRAHAM CRACKERSMILD HYPOGLYCEMIA MANAGEMENT
  79. 79. RETEST BLOOD GLUCOSE LEVELS IN 15 MINSONCE SYMPTOMS RESOLVE, GIVE 2 SLICES OFSANDWICH OR CRACKERS, THEN PROVIDEREGULAR MEAL WITHIN 60 MINUTESMILD HYPOGLYCEMIA MANAGEMENT
  80. 80. 15 TO 30 G OF FAST ACTING SIMPLECARBOHYDRATEGIVE ADDITIONAL FOOD AFTER 10 TO 15 MINSRETEST BLOOD GLUCOSE LEVELS IN 15 MINSMODERATE HYPOGLYCEMIA MANAGEMENT
  81. 81. GLUCAGON ADMINISTERED SUBQ, IM OR IVNOTIFY PHYSICIAN IF SEVERE HYPOGLYCEMICREACTION OCCURSADMINISTER 50% DEXTROSE IN WATER, 25 TO 50ML PER IV AS ORDEREDSMALL MEAL IF CLIENT HAS AWAKENEDSEVERE HYPOGLYCEMIA MANAGEMENT
  82. 82. UNDERDOSE OR MISSED INSULINILLNESS OR INFECTIONOVEREATINGSTRESS OR SURGERYUNTREATED TYPE I DMDIABETIC KETOACIDOSIS CAUSES
  83. 83. HYPERGLYCEMIADEHYDRATIONELECTROLYTE LOSSACIDOSISDIABETIC KETOACIDOSIS MANIFESTATIONS
  84. 84. ACETONE BREATHANOREXIA, N & V, ABDOMINAL PAINBLURRED VISIONHEADACHEHYPOTENSIONKUSSMAUL’S RESPIRATIONMENTAL STATUS CHANGESDIABETIC KETOACIDOSIS MANIFESTATIONS
  85. 85. POLYDIPSIAPOLYURIAWEAK, RAPID PULSEWEAKNESSDIABETIC KETOACIDOSIS MANIFESTATIONS
  86. 86. MAINTAIN PATENT AIRWAYADMINISTER OXYGEN AS PRESCRIBEDNORMAL SALINE 0.9 % RAPID IVD5NS OR 5% DEXTROSE IN 0.45% SALINE FORBLOOD GLUCOSE 250 TO 350 MG/DLREGULAR INSULIN IV AS PRESCRIBEDDIABETIC KETOACIDOSIS MANAGEMENT
  87. 87. MIX PRESCRIBED IV DOSE OF INSULIN TOSALINE SOLUTION FORCONTINUOUS INFUSIONMONITOR SERUM POTASSIUM LEVELS,GLUCOSE, AND URINE OUTPUTCORRECT ELECTROLYE IMBALANCESDIABETIC KETOACIDOSIS MANAGEMENT
  88. 88. BLOOD GLUCOSE LEVEL OF 600 TO 2,000 MG/DLHYPOTENSIONDEHYDRATIONMENTAL STATUS CHANGESTACHYCARDIANEUROLOGIC DEFICITSSEIZURESHYPERGLYCEMIC HYPEROSMOLARNONKETOTIC SYNDROME
  89. 89. FLUID REPLACEMENTCORRECTION OF ELECTROLYTE IMBALANCESINSULIN ADMINISTRATIONHYPERGLYCEMIC HYPEROSMOLARNONKETOTIC SYNDROME
  90. 90. HYPERTHERMIATACHYCARDIA & DYSRHYTHMIASSYSTOLIC HYPERTENSIONN & V AND DIARRHEARESTLESSNESS, AGITATION, IRRITABILITY,ANXIETY, TREMORS, CONFUSION, SEIZURESDELIRIUM & COMATHYROID STORM / THYROTOXICOSIS
  91. 91. MAINTAIN PATENT AIRWAY & ADEQUATEVENTILATIONADMINISTER ANTITHYROID MEDICATIONS (PTU),SODIUM IODIDE (LUGOL’S SOLUTION),INDERAL (PROPANOLOL), ANDGLUCOCORTICOIDS (DEXAMETHASONE)MONITOR VS, I & O, NEUROLOGIC STATUS, CVSTATUS EVERY HOURTHYROID STORM / THYROTOXICOSIS
  92. 92. INITIATE MEASURES TO LOWER FEVERMAINTAIN QUIET, CALM AND COOLENVIRONMENTTHYROID STORM / THYROTOXICOSIS
  93. 93. HYPOTENSIONBRADYCARDIAHYPOTHERMIAHYPOGLYCEMIAHYPONATREMIARESPIRATORY FAILURECOMAMYXEDEMA COMA
  94. 94. MAINTAIN PATENT AIRWAYADMINISTER IV FLUIDSSYNTHROID IV AS PRESCRIBEDGLUCOSE IV AS PRESCRIBEDMONITOR AND MANAGE HYPOTHERMIAMONITOR AND MANAGE HYPOTENSIONMONITOR FOR CHANGES IN THE LOCMONITOR FOR ELECTROLYE LEVELSMYXEDEMA COMA
  95. 95. SEVERE HEADACHESEVERE ABDOMINAL, LEG ANDLOWER BACK PAINGENERALIZED WEAKNESSIRRITABILITY AND CONFUSIONSEVERE HYPOTENSIONSHOCKADDISONIAN CRISIS
  96. 96. ADMINISTER GLUCOCORTICOIDSSOLU-CORTEF / HYDROCORTISONESODIUM SUCCINATEMONITOR VSMONITOR NEUROLOGICAL STATUSMONITOR INTAKE AND OUTPUTMONITOR ELECTROLYTES AND GLUCOSEADDISONIAN CRISIS
  97. 97. 5 H’SHHHHHPHEOCHROMOCYTOMA
  98. 98. MONITOR VITAL SIGNSMONITOR BLOOD GLUCOSE AND URINEFOR KETONESPROMOTE BED RESTAVOID SMOKING, DRINKING CAFFEINATEDBEVERAGES, AND CHANGING POSITIONSUDDENLYPHEOCHROMOCYTOMA
  99. 99. ADMINISTER ALPHA-ADRENERGIC AGENTSPREPARE FOR SURGERYADRENALECTOMYPHEOCHROMOCYTOMA
  100. 100. HYPOVOLEMIC SHOCKCARDIOGENIC SHOCKDISTRIBUTIVE SHOCK / VASOGENIC SHOCKNEUROGENIC / SPINAL SHOCKSEPTIC SHOCK / TOXIC SHOCKANAPHYLACTIC SHOCKCLASSIFICATIONS
  101. 101. SYMPATHO-ADRENO-MEDULLARY RESPONSEANTIDIURETIC HORMONE RELEASERENIN-ANGIOTENSIN-ALDOSTERONE SYSTEMSYMPATHETIC NERVOUS SYSTEMINITIAL STAGE
  102. 102. TUBULAR NECROSIS AND RENAL FAILURECEREBRAL HYPOXIA, ALTERED LOCCARDIAC ARREST AND DYSRHYTHMIASACUTE RESPIRATORY DISTRESS SYNDROMEPARALYTIC ILEUSDECOMPENSATED / PROGRESSIVE STAGE
  103. 103. DECREASED METABOLIC FUNCTIONOF THE LIVERDISSEMINATED INTRAVASCULAR COAGULATIONDECOMPENSATED / PROGRESSIVE STAGE
  104. 104. RESTLESSNESS AND CONFUSIONTACHYCARDIA AND TACHYPNEADIAPHORESIS, COLD CLAMMY SKINDECREASED BODY TEMPERATUREDECREASED URINE OUTPUTRESPIRATORY ALKALOSISEARLY STAGE MANIFESTATIONS
  105. 105. HYPOTENSIONOLIGURIA TO ANURIASHALLOW RESPIRATIONHYPOTHERMIADECREASED BOWEL SOUNDSRESPIRATORY AND METABOLIC ACIDOSISLATE STAGE MANIFESTATIONS
  106. 106. PROMOTE FLUID BALANCE ANDCARDIAC OUTPUTASSIST IN CARDIAC SUPPORTMODIFIED TRENDELENBURGINTRAAORTIC BALLON PUMP (IABP)MEDICAL ANTI-SHOCK TROUSER (MAST)MANAGEMENT
  107. 107. ASSIST IN RESPIRATORY SUPPORTASSIST IN RENAL SUPPORTDOBUTAMINEPROMOTE SAFETYMANAGEMENT
  108. 108. VASOCONSTRICTORSNOREPINEPHRINE (LEVARTERENOL)EPINEPHRINEDOPAMINEDOBUTAMINEMANAGEMENT
  109. 109. VASODILATORSNITROPRUSSIDE (NIPRIDE)NITROGLYCERINE (ISOSORBIDE)PHENTOLAMINE (REGITINE)HYDRALAZINE (APRESOLINE)MANAGEMENT
  110. 110. NA BICARBONATEANTIBIOTICSHEPARINSTERIODSGLUCAGONCIMETIDINEMANAGEMENT
  111. 111. TOURNIQUETPRESSURE POINTSEXTERNAL BLEEDING

×